Display options
Cite
Wise PM, Neviani P, Riwaldt S, et al. Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222312841.
Wise, P. M., Neviani, P., Riwaldt, S., Corydon, T. J., Wehland, M., Braun, M., Krüger, M., Infanger, M., & Grimm, D. (2021). Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222312841
Wise, Petra M, et al. "Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222312841
Wise PM, Neviani P, Riwaldt S, Corydon TJ, Wehland M, Braun M, Krüger M, Infanger M, Grimm D. Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space. Int J Mol Sci. 2021 Nov 27;22(23). doi: 10.3390/ijms222312841. PMID: 34884646; PMCID: PMC8657878.
Copy Download .nbib Format: NLM
Share it on

Int J Mol Sci. 2021 Nov 27;22(23). doi: 10.3390/ijms222312841.

Changes in Exosomal miRNA Composition in Thyroid Cancer Cells after Prolonged Exposure to Real Microgravity in Space.

International journal of molecular sciences

Petra M Wise, Paolo Neviani, Stefan Riwaldt, Thomas J Corydon, Markus Wehland, Markus Braun, Marcus Krüger, Manfred Infanger, Daniela Grimm

Affiliations

  1. The Saban Research Institute, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Blvd., Los Angeles, CA 90027, USA.
  2. Department of Microgravity and Translational Regenerative Medicine, Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany.
  3. Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus C, Denmark.
  4. Department of Ophthalmology, Aarhus University Hospital, 8200 Aarhus N, Denmark.
  5. Research Group "Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen" (MARS), Otto von Guericke University, 39106 Magdeburg, Germany.
  6. Deutsches Zentrum für Luft- und Raumfahrt (DLR), Raumfahrtagentur im DLR, Bonn-Oberkassel, 53227 Bonn, Germany.

PMID: 34884646 PMCID: PMC8657878 DOI: 10.3390/ijms222312841

Abstract

As much as space travel and exploration have been a goal since humankind looked up to the stars, the challenges coming with it are manifold and difficult to overcome. Therefore, researching the changes the human organism undergoes following exposure to weightlessness, on a cellular or a physiological level, is imperative to reach the goal of exploring space and new planets. Building on the results of our CellBox-1 experiment, where thyroid cancer cells were flown to the International Space Station, we are now taking advantage of the newest technological opportunities to gain more insight into the changes in cell-cell communication of these cells. Analyzing the exosomal microRNA composition after several days of microgravity might elucidate some of the proteomic changes we have reported earlier. An array scan of a total of 754 miRNA targets revealed more than 100 differentially expressed miRNAs in our samples, many of which have been implicated in thyroid disease in other studies.

Keywords: cell culture; exosomes; miRNA; microgravity; spaceflight; thyroid cancer

References

  1. Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10275-10280 - PubMed
  2. Oncotarget. 2016 May 3;7(18):26593-603 - PubMed
  3. Gynecol Oncol. 2011 Apr;121(1):200-5 - PubMed
  4. Trends Cell Biol. 2017 Mar;27(3):172-188 - PubMed
  5. Technol Cancer Res Treat. 2018 Jan 1;17:1533034618775509 - PubMed
  6. Nat Cell Biol. 2008 Dec;10(12):1470-6 - PubMed
  7. Cell. 2012 Dec 21;151(7):1542-56 - PubMed
  8. Cancer Cell Int. 2020 May 1;20:145 - PubMed
  9. Med Sci Sports Exerc. 1996 Oct;28(10):1247-53 - PubMed
  10. Adv Space Res. 1999;24(6):793-800 - PubMed
  11. Med Sci Monit. 2016 Apr 11;22:1210-7 - PubMed
  12. Pharmacol Ther. 2017 Jun;174:63-78 - PubMed
  13. Biomed Pharmacother. 2019 Jul;115:108947 - PubMed
  14. Nature. 2001 Jan 18;409(6818):363-6 - PubMed
  15. Oncogene. 2017 Mar 30;36(13):1770-1778 - PubMed
  16. Planta. 1997;203 Suppl:S187-97 - PubMed
  17. Cancer Lett. 2013 Feb 1;329(1):84-90 - PubMed
  18. Onco Targets Ther. 2020 Oct 09;13:10173-10184 - PubMed
  19. J Clin Pharmacol. 1994 May;34(5):518-34 - PubMed
  20. Circ Res. 2020 Jun 5;126(12):e120-e135 - PubMed
  21. Science. 2001 Oct 26;294(5543):862-4 - PubMed
  22. Onco Targets Ther. 2015 Aug 26;8:2271-7 - PubMed
  23. Noncoding RNA Res. 2020 Jun 20;5(3):88-98 - PubMed
  24. Surgery. 2010 Dec;148(6):1147-52; discussion 1152-3 - PubMed
  25. Nature. 2000 Feb 24;403(6772):901-6 - PubMed
  26. Biochim Biophys Acta Gene Regul Mech. 2020 Jun;1863(6):194417 - PubMed
  27. Cytometry A. 2010 Jun;77(6):502-14 - PubMed
  28. J Cell Biochem. 2019 Aug;120(8):13562-13572 - PubMed
  29. Med Sci Sports Exerc. 1996 Aug;28(8):983-7 - PubMed
  30. FASEB J. 2012 Dec;26(12):5124-40 - PubMed
  31. Biosci Rep. 2018 Jul 31;38(4): - PubMed
  32. Biomed Pharmacother. 2019 Jan;109:1960-1966 - PubMed
  33. Lancet Diabetes Endocrinol. 2021 Apr;9(4):193-194 - PubMed
  34. Pharm Res. 2010 May;27(5):796-810 - PubMed
  35. Acta Neurol Scand. 2020 Nov;142(5):511-516 - PubMed
  36. J Vis Exp. 2012 Jan 09;(59):e3037 - PubMed
  37. Science. 2019 Apr 12;364(6436): - PubMed
  38. Sci Am. 1998 Sep;279(3):58-63 - PubMed
  39. J Extracell Vesicles. 2019 Nov 20;9(1):1692401 - PubMed
  40. Sci Rep. 2018 Jan 17;8(1):921 - PubMed
  41. Am J Ther. 2017 May;24(3):e317-e328 - PubMed
  42. Nat Commun. 2016 Mar 29;7:11150 - PubMed
  43. Astrobiology. 2013 Jan;13(1):1-17 - PubMed
  44. Nature. 2001 Feb 22;409(6823):1115-8 - PubMed
  45. J Exp Med. 2002 May 20;195(10):1303-16 - PubMed
  46. Cancer Manag Res. 2020 Sep 22;12:8745-8756 - PubMed
  47. Expert Rev Proteomics. 2019 Jan;16(1):17-31 - PubMed
  48. Nature. 2000 Nov 2;408(6808):86-9 - PubMed
  49. Sensors (Basel). 2015 Jul 20;15(7):17649-65 - PubMed
  50. J Extracell Vesicles. 2014 Dec 22;3:26913 - PubMed
  51. Sci Rep. 2016 Nov 17;6:37246 - PubMed
  52. Gynecol Oncol. 2009 Sep;114(3):457-64 - PubMed
  53. BMC Cancer. 2016 Nov 14;16(1):887 - PubMed
  54. Biochem Biophys Res Commun. 2017 Feb 19;483(4):1178-1186 - PubMed
  55. FASEB J. 2014 Feb;28(2):813-35 - PubMed
  56. IUBMB Life. 2019 Jan;71(1):28-40 - PubMed
  57. Science. 2001 Oct 26;294(5543):853-8 - PubMed
  58. Biomed Res Int. 2020 Dec 28;2020:8895003 - PubMed
  59. Oncol Lett. 2019 Dec;18(6):6670-6678 - PubMed
  60. Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 - PubMed
  61. Cell. 1993 Dec 3;75(5):843-54 - PubMed
  62. Neoplasma. 2020 Mar;67(2):215-228 - PubMed
  63. Mol Med. 2019 Mar 20;25(1):7 - PubMed
  64. EMBO J. 2017 Nov 15;36(22):3336-3355 - PubMed
  65. Cell. 1993 Dec 3;75(5):855-62 - PubMed
  66. Mol Ther Nucleic Acids. 2019 Sep 6;17:347-361 - PubMed
  67. Biol Proced Online. 2021 Sep 7;23(1):17 - PubMed
  68. Int J Mol Sci. 2021 Feb 21;22(4): - PubMed
  69. Nat Rev Cancer. 2012 Jun 22;12(7):447 - PubMed
  70. Nat Rev Cancer. 2018 Jan;18(1):5-18 - PubMed
  71. Int J Mol Sci. 2016 Apr 08;17(4):528 - PubMed
  72. J Leukoc Biol. 1993 Sep;54(3):179-88 - PubMed
  73. Cell. 2018 Mar 22;173(1):20-51 - PubMed
  74. Endocr J. 2021 May 28;68(5):583-597 - PubMed
  75. Aviat Space Environ Med. 2006 Nov;77(11):1113-6 - PubMed
  76. Proteomics. 2015 Sep;15(17):2945-52 - PubMed
  77. Methods Mol Biol. 2017;1660:91-103 - PubMed
  78. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3687-92 - PubMed
  79. Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):171-180 - PubMed
  80. Biochem Biophys Res Commun. 2018 Feb 26;497(1):181-186 - PubMed
  81. Sci Rep. 2018 Feb 5;8(1):2375 - PubMed
  82. Cell. 2019 Nov 14;179(5):1033-1055 - PubMed
  83. Cell Mol Life Sci. 2018 Jan;75(2):193-208 - PubMed
  84. Cell Cycle. 2015;14(4):481-7 - PubMed
  85. J Clin Invest. 2016 Sep 1;126(9):3219-35 - PubMed
  86. Nanomedicine. 2011 Dec;7(6):780-8 - PubMed
  87. Mol Oncol. 2017 Sep;11(9):1241-1262 - PubMed
  88. Sci Rep. 2018 Jul 9;8(1):10355 - PubMed
  89. FASEB J. 2012 May;26(5):1791-8 - PubMed
  90. Methods Mol Biol. 2017;1660:111-130 - PubMed
  91. EMBO J. 2004 Oct 13;23(20):4051-60 - PubMed
  92. Langmuir. 2011 Dec 6;27(23):14394-400 - PubMed
  93. Reprod Sci. 2020 Jan;27(1):110-118 - PubMed
  94. Nat Rev Genet. 2008 Feb;9(2):102-14 - PubMed
  95. Expert Rev Mol Diagn. 2015;15(12):1577-88 - PubMed
  96. Biomaterials. 2013 Oct;34(31):7694-705 - PubMed
  97. Trends Immunol. 2010 May;31(5):199-204 - PubMed
  98. Int J Mol Sci. 2015 Nov 30;16(12):28296-310 - PubMed
  99. J Clin Invest. 2016 Nov 1;126(11):4140-4156 - PubMed
  100. J Endocr Soc. 2017 Jan 12;1(1):3-13 - PubMed
  101. Nat Med. 2012 Jun 06;18(6):853-4 - PubMed
  102. Cell Rep. 2021 Jan 26;34(4):108672 - PubMed
  103. Nature. 2003 Sep 25;425(6956):415-9 - PubMed
  104. Cell Biochem Biophys. 2014 Sep;70(1):215-24 - PubMed
  105. Mol Aspects Med. 2018 Apr;60:15-26 - PubMed
  106. J Transl Med. 2020 Feb 3;18(1):51 - PubMed
  107. Onco Targets Ther. 2019 Mar 28;12:2323-2333 - PubMed
  108. J Am Soc Nephrol. 2009 Feb;20(2):363-79 - PubMed
  109. Cell Rep. 2016 May 3;15(5):978-987 - PubMed
  110. Mol Med Rep. 2020 Sep;22(3):2307-2317 - PubMed
  111. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):548-554 - PubMed
  112. J Extracell Vesicles. 2018 Nov 23;7(1):1535750 - PubMed
  113. Musculoskelet Sci Pract. 2017 Jan;27 Suppl 1:S15-S22 - PubMed
  114. Genes Dev. 2001 Oct 15;15(20):2654-9 - PubMed
  115. Nat Cell Biol. 2008 May;10(5):619-24 - PubMed
  116. J Exp Clin Cancer Res. 2017 Mar 7;36(1):40 - PubMed
  117. Musculoskelet Sci Pract. 2017 Jan;27 Suppl 1:S23-S31 - PubMed
  118. Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):619-632 - PubMed
  119. Nat Med. 2012 Jun;18(6):883-91 - PubMed
  120. Trends Cell Biol. 2004 Apr;14(4):156-9 - PubMed
  121. J Leukoc Biol. 2003 Apr;73(4):472-81 - PubMed
  122. Expert Rev Mol Diagn. 2014 Jun;14(5):565-74 - PubMed
  123. Cancer Res. 2011 Jun 1;71(11):3792-801 - PubMed
  124. Cell Mol Neurobiol. 2016 Apr;36(3):301-12 - PubMed
  125. Annu Rev Cell Dev Biol. 2014;30:255-89 - PubMed
  126. J Nanobiotechnology. 2020 Mar 16;18(1):47 - PubMed
  127. PLoS One. 2011;6(8):e22828 - PubMed
  128. Carcinogenesis. 2017 May 1;38(5):485-491 - PubMed
  129. J Cell Mol Med. 2020 May;24(10):5555-5564 - PubMed
  130. Curr Mol Med. 2011 Jul;11(5):350-64 - PubMed
  131. Bioengineering (Basel). 2019 Jan 16;6(1): - PubMed
  132. J Extracell Vesicles. 2016 Oct 31;5:32945 - PubMed
  133. Gastroenterology. 2005 Jun;128(7):1796-804 - PubMed
  134. Adv Space Biol Med. 1999;7:99-129 - PubMed
  135. Vaccines (Basel). 2016 Oct 20;4(4): - PubMed
  136. Hum Pathol. 2018 Sep;79:212-221 - PubMed
  137. Nat Cell Biol. 2015 Jun;17(6):816-26 - PubMed
  138. Br J Biomed Sci. 2017 Apr;74(2):90-94 - PubMed
  139. Science. 2001 Aug 3;293(5531):834-8 - PubMed

Publication Types

Grant support